{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:27:38Z","timestamp":1793924858779,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vaccine.2026.129237","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:49:36Z","timestamp":1792345776000},"page":"129237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["AEX-1: A Vero cell variant with enhanced permissiveness for influenza virus replication"],"prefix":"10.1016","volume":"94","author":[{"given":"Artem","family":"Krokhin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Romanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Grillari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hackl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Korabliov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Mand\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Egorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2026.129237_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8020211","article-title":"Pandemic influenza vaccines: what did we learn from the 2009 pandemic and are we better prepared now?","volume":"8","author":"Rockman","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129237_bb0010","first-page":"Doc21","article-title":"Cell-based influenza vaccines: an effective vaccine option for under 60-year-olds. GMS Hyg","volume":"19","author":"Gartner","year":"2024","journal-title":"Infect Control"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129237_bb0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1586\/14760584.2015.1039520","article-title":"Flucelvax (Optaflu) for seasonal influenza","volume":"14","author":"Manini","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129237_bb0020","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40265-019-01176-z","article-title":"Cell-based quadrivalent inactivated influenza virus vaccine (Flucelvax((R)) Tetra\/Flucelvax Quadrivalent((R))): a review in the prevention of influenza","volume":"79","author":"Lamb","year":"2019","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129237_bb0025","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1128\/JCM.00398-08","article-title":"MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells","volume":"46","author":"Oh","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129237_bb0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jviromet.2013.04.020","article-title":"Comparison of initial feasibility of host cell lines for viral vaccine production","volume":"193","author":"Vlecken","year":"2013","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129237_bb0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41541-025-01157-2","article-title":"Characterization of a suspension Vero cell line for viral vaccine production","volume":"10","author":"Bourigault","year":"2025","journal-title":"NPJ Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129237_bb0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1586\/erv.12.24","article-title":"Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production","volume":"11","author":"Montomoli","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129237_bb0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00253-010-2742-9","article-title":"MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation","volume":"88","author":"Genzel","year":"2010","journal-title":"Appl Microbiol Biotechnol"},{"issue":"43","key":"10.1016\/j.vaccine.2026.129237_bb0050","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1016\/j.vaccine.2012.07.077","article-title":"Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming","volume":"30","author":"van der Velden","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129237_bb0055","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1586\/erv.12.55","article-title":"Preflucel(R): a Vero-cell culture-derived trivalent influenza vaccine","volume":"11","author":"Chan","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129237_bb0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/tra.12389","article-title":"Fusion of enveloped viruses in endosomes","volume":"17","author":"White","year":"2016","journal-title":"Traffic"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129237_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-1702(01)00260-X","article-title":"Apoptosis by influenza viruses correlates with efficiency of viral mRNA synthesis","volume":"77","author":"Stray","year":"2001","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129237_bb0070","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1128\/JVI.06009-11","article-title":"Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion","volume":"86","author":"Murakami","year":"2012","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129237_bb0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/biot.201300225","article-title":"Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines","volume":"9","author":"Nakowitsch","year":"2014","journal-title":"Biotechnol J"},{"issue":"19","key":"10.1016\/j.vaccine.2026.129237_bb0080","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.vaccine.2011.02.100","article-title":"Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1","volume":"29","author":"Nakowitsch","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129237_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18527\/2500-2236-2017-4-1-1-9","article-title":"Influenza vaccines manufacturing in continuous cell lines: problems and solutions","volume":"4","author":"Romanova","year":"2017","journal-title":"MIR J"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129237_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018577","article-title":"Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1","volume":"6","author":"Krenn","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.129237_bb0095","doi-asserted-by":"crossref","first-page":"127795","DOI":"10.1016\/j.vaccine.2025.127795","article-title":"Protective efficacy of the UniFluVec influenza vaccine vector against the highly pathogenic influenza a\/Indonesia\/5\/2005 (H5N1) strain in ferrets","volume":"65","author":"Romanova","year":"2025","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129237_bb0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.18527\/2024111024","article-title":"Single intranasal immunization with a high dose of influenza vector protects against infection with heterologous influenza virus and SARS-CoV-2 in ferrets and hamsters","volume":"11","author":"Egorov","year":"2024","journal-title":"MIR J"},{"key":"10.1016\/j.vaccine.2026.129237_bb0105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1472-6750-11-102","article-title":"Authentication of African green monkey cell lines using human short tandem repeat markers","volume":"11","author":"Almeida","year":"2011","journal-title":"BMC Biotechnol"},{"issue":"W1","key":"10.1016\/j.vaccine.2026.129237_bb0110","doi-asserted-by":"crossref","first-page":"W566","DOI":"10.1093\/nar\/gkv468","article-title":"ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129237_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0042-6822(02)00064-8","article-title":"Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern","volume":"307","author":"Romanova","year":"2003","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129237_bb0120","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10616-017-0082-7","article-title":"Potential neoplastic evolution of Vero cells: in vivo and in vitro characterization","volume":"69","author":"Andreani","year":"2017","journal-title":"Cytotechnology"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129237_bb0125","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/dnares\/dsu029","article-title":"The genome landscape of the African green monkey kidney-derived Vero cell line","volume":"21","author":"Osada","year":"2014","journal-title":"DNA Res"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129237_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/v13050746","article-title":"Hemagglutinin stability and its impact on influenza a virus infectivity, pathogenicity, and transmissibility in avians, mice, swine, seals, ferrets, and humans","volume":"13","author":"Russell","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129237_bb0135","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1073\/pnas.1524384113","article-title":"Molecular requirements for a pandemic influenza virus: an acid-stable hemagglutinin protein","volume":"113","author":"Russier","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129237_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.18527\/2500-2236-2014-1-1-12-26","article-title":"H5N1 influenza vaccine quality is affected by hemagglutinin conformational stability","volume":"1","author":"Sergeeva","year":"2014","journal-title":"MIR J"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129237_bb0145","first-page":"70","article-title":"Unifluvec influenza vector induces heterosubtypic protection in ferrets after intranasal administration despite high attenuation","volume":"11","author":"Ferko","year":"2024","journal-title":"Microbiol Ind Res J (MIR J)"},{"key":"10.1016\/j.vaccine.2026.129237_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41541-018-0079-z","article-title":"Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness","volume":"3","author":"Barr","year":"2018","journal-title":"NPJ Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:54:01Z","timestamp":1793922841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26010467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":30,"alternative-id":["S0264410X26010467"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129237","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AEX-1: A Vero cell variant with enhanced permissiveness for influenza virus replication","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129237"}}